EUCTR2006-002716-94-IS进行中（未招募）1 期
AD/HD diagnosis through EEG, a pilot study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Healthy subjects:
- •–Between 6-8 years of age
- •–On the parent-completed SDQ, scores on the four proplem subscales (Hyperactivity, Emotional Problems, Conduct Problems, Peer Problems) should not exceed 1.0 standard deviation above the age appropriate mean. On the AD/HD Rating scale-IV, Inattention and Hyperactivity subscores should not exceed one standard deviation above the mean. The means and standard deviations mentioned here refer to Icelandic norms.
- •AD/HD subjects:
- •–Between 6-8 years of age
- •–Recently diagnosed with AD/HD according to DSM-IV
- •–Other possibilities have been exhausted and treatment using methylphenidate (Ritalin®) is the only viable option left
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •–Individual has Tourette syndrome
- •–Individual suffers from psychosis
- •–Individual suffers from mental retardation
- •–Individual allergic to the investigational material
- •–Individual is receiving treatment for other diseases affecting the central nervous system
- •–Hypersensitivity to methylphenidate or any other component in the Ritalin® formulation
- •–Participation in another investigational study at the same time
研究者
相似试验
进行中（未招募）
不适用
Etude pilote des signes électro-encéphalographiques de réveil secondaire à l’injection de sugammadex : évaluation par l’enregistrement de l’Index Bispectral et du NeuroSENSE (étude prospective, randomisée, monocentrique et réalisée en double aveugle) - Suggamadex-RéveilEUCTR2010-018303-28-FRHopital Foch
招募中
不适用
Cognitive- and EEG-diagnostic markers of ADHD-symptomsADHDattention deficit/hyperactivity disorder10009841NL-OMON39997niversiteit Maastricht75
已完成
2 期
A Pilot Electroencephalography (EEG) Study to Evaluate the Effect of CT1812 Treatment on Synaptic Activity in Subjects With Mild to Moderate Alzheimer*s Disease10012272DementiaAlzheimer's DiseaseNL-OMON54794Julius Clinical16
进行中（未招募）
1 期
A Pilot Clinical Study to evaluate the effect of CT1812 in subjects with Mild to Moderate Alzheimer’s Disease Using EEGMild to Moderate Alzheimer’s DiseaseMedDRA version: 20.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852EUCTR2019-003552-36-NLCognition Therapeutics, Inc.16
撤回
不适用
Electroencephalogram and Attention Deficit Hyperactivity Disorder StudyHealthy ControlsAttention Deficit Hyperactivity DisorderNCT02154321University of Michigan